Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolai A Schultz

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Cancers|November 28, 2013
YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Nicolai A Schultz, Julia S Johansen
Future Oncology (London, England)|October 2, 2009
Plasma YKL-40: a potential new cancer biomarker?Julia S Johansen, Nicolai A Schultz, Benny V Jensen
World Journal of Surgery|August 2, 2012
Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic indexNicolai A Schultz, Klaus K Andersen, Anne Roslind, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 11, 2012
MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinomaNicolai A Schultz, Jens Werner, Hanni Willenbrock, et al.
World Journal of Surgery|January 6, 2018
Second Generation of a Fast-track Liver Resection ProgrammeNicolai A Schultz, Peter N Larsen, B Klarskov, et al.
Acta Anaesthesiologica Scandinavica|March 24, 2022
High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudyHussein Nasser Awada, Kristin Julia Steinthorsdottir, Nicolai A Schultz, et al.
Annals of Surgery|January 18, 2018
Response: "Unresectable Colorectal Liver Metastases: When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques"Per Sandström, Bård I Rösok, Ernesto Sparrelid, et al.
International Journal of Surgery (London, England)|February 1, 2020
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort studyBergthor Björnsson, Kristina Hasselgren, Bård Røsok, et al.
Annals of Surgery|September 1, 2018
Response to Comment on "When Innovation Is Not Enough"Per Sandström, Anna Lindhoff Larsson, Bergthor Björnsson, et al.
Annals of Surgery|March 21, 2018
Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?"Per Sandström, Bård I Røsok, Ernesto Sparrelid, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Cancers|November 28, 2013
YKL-40-A Protein in the Field of Translational Medicine: A Role as a Biomarker in Cancer Patients?Nicolai A Schultz, Julia S Johansen
Future Oncology (London, England)|October 2, 2009
Plasma YKL-40: a potential new cancer biomarker?Julia S Johansen, Nicolai A Schultz, Benny V Jensen
World Journal of Surgery|August 2, 2012
Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--five microRNAs in a prognostic indexNicolai A Schultz, Klaus K Andersen, Anne Roslind, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 11, 2012
MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinomaNicolai A Schultz, Jens Werner, Hanni Willenbrock, et al.
World Journal of Surgery|January 6, 2018
Second Generation of a Fast-track Liver Resection ProgrammeNicolai A Schultz, Peter N Larsen, B Klarskov, et al.
Acta Anaesthesiologica Scandinavica|March 24, 2022
High-dose preoperative glucocorticoid for prevention of emergence and postoperative delirium in liver resection: A double-blinded randomized clinical trial substudyHussein Nasser Awada, Kristin Julia Steinthorsdottir, Nicolai A Schultz, et al.
Annals of Surgery|January 18, 2018
Response: "Unresectable Colorectal Liver Metastases: When Definitions Matter to Appropriately Assess Extreme Liver Resection Techniques"Per Sandström, Bård I Rösok, Ernesto Sparrelid, et al.
International Journal of Surgery (London, England)|February 1, 2020
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy - A Scandinavian cohort studyBergthor Björnsson, Kristina Hasselgren, Bård Røsok, et al.
Annals of Surgery|September 1, 2018
Response to Comment on "When Innovation Is Not Enough"Per Sandström, Anna Lindhoff Larsson, Bergthor Björnsson, et al.
Annals of Surgery|March 21, 2018
Response to the Comment on "Should We Have a Little More Patience With the Conventional 2-Stage Hepatectomy?"Per Sandström, Bård I Røsok, Ernesto Sparrelid, et al.
Pageof 3